Greenwich Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Buy |
14,044
+4
| +0% | +$743 | 0.13% | 75 |
|
|
2025
Q1 | $2.94M | Sell |
14,040
-206
| -1% | -$43.2K | 0.22% | 58 |
|
|
2024
Q4 | $2.53M | Buy |
14,246
+24
| +0.2% | +$4.27K | 0.18% | 64 |
|
|
2024
Q3 | $2.81M | Buy |
14,222
+34
| +0.2% | +$6.72K | 0.19% | 64 |
|
|
2024
Q2 | $2.43M | Sell |
14,188
-6
| -0% | -$1.03K | 0.18% | 67 |
|
|
2024
Q1 | $2.59M | Buy |
14,194
+116
| +0.8% | +$21.1K | 0.21% | 65 |
|
|
2023
Q4 | $2.18M | Sell |
14,078
-82
| -0.6% | -$12.7K | 0.22% | 66 |
|
|
2023
Q3 | $2.11M | Buy |
14,160
+994
| +8% | +$148K | 0.22% | 59 |
|
|
2023
Q2 | $1.77M | Sell |
13,166
-189
| -1% | -$25.5K | 0.19% | 77 |
|
|
2023
Q1 | $2.13M | Buy |
13,355
+42
| +0.3% | +$6.69K | 0.23% | 66 |
|
|
2022
Q4 | $2.15M | Buy |
13,313
+397
| +3% | +$64.1K | 0.24% | 66 |
|
|
2022
Q3 | $1.73M | Sell |
12,916
-703
| -5% | -$94.3K | 0.18% | 78 |
|
|
2022
Q2 | $2.09M | Buy |
13,619
+703
| +5% | +$108K | 0.28% | 65 |
|
|
2022
Q1 | $2.09M | Sell |
12,916
-28
| -0.2% | -$4.54K | 0.21% | 74 |
|
|
2021
Q4 | $1.75M | Buy |
12,944
+19
| +0.1% | +$2.57K | 0.14% | 81 |
|
|
2021
Q3 | $1.39M | Buy |
12,925
+1,010
| +8% | +$109K | 0.12% | 90 |
|
|
2021
Q2 | $1.34M | Sell |
11,915
-870
| -7% | -$98K | 0.11% | 90 |
|
|
2021
Q1 | $1.38M | Buy |
12,785
+362
| +3% | +$39.2K | 0.11% | 88 |
|
|
2020
Q4 | $1.33M | Buy |
12,423
+531
| +4% | +$56.9K | 0.12% | 82 |
|
|
2020
Q3 | $1.04M | Buy |
11,892
+5
| +0% | +$438 | 0.19% | 85 |
|
|
2020
Q2 | $1.17M | Buy |
11,887
+222
| +2% | +$21.8K | 0.22% | 78 |
|
|
2020
Q1 | $889K | Buy |
+11,665
| New | +$889K | 0.19% | 77 |
|